RAD News 6.99 04/28/2014 05:58:19 Rite Aid Corp (RAD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Rite Aid Corp (RAD) 6.99 $RAD

Myers Posts Dismal Q1 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 25, 10:20AM CDT
Myers (MYE) first-quarter 2014 earnings of 16 cents a share missed the Zacks Consensus Estimate of 22 cents and fell 33% year over year.

Whirlpool Q1 Earnings Miss but Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 25, 9:27AM CDT
Whirlpool Corporation's (WHR) adjusted earnings per share came in at $2.20 in the first quarter of 2014, way below the Zacks Consensus Estimate of $2.30.

Active Health Foods Eyes Shelf Space in Major National Stores
Marketwire - Fri Apr 25, 9:15AM CDT
America's top retailers may soon be making shelf space available for a new line of All Natural, Sugar Free, Organic, and Gluten Free products. Active Health Foods, Incorporated (OTCQB: AHFD) has hired renowned consulting firm Queathem & Associates, Inc. of Irvine, California to secure placement of its products in Major and Independent Grocery, Drug, and Convenience Chains.

Today's Review on Active Stocks -- Research on Yahoo!, Peabody Energy, Rite Aid, and Comcast
PR Newswire - Fri Apr 25, 8:37AM CDT
On Thursday, April 24, 2014, the NASDAQ Composite ended at 4,148.34, up 0.52%, the Dow Jones Industrial Average finished the session flat at 16,501.65, and the S&P 500 closed at 1,878.61, up 0.17%. During the trading session, four out of ten sectors finished on a higher note. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Yahoo! Inc. (NASDAQ: YHOO), Peabody Energy Corp. (NYSE: BTU), Rite Aid Corp. (NYSE: RAD) and Comcast Corp. (NASDAQ: CMCSA). Free technical research on YHOO, BTU, RAD and CMCSA can be downloaded upon signing up at:

Rite Aid, Guess?, Amazon, Microsoft and Netflix highlighted as Zacks Bull and Bear of the Day
PR Newswire - Fri Apr 25, 8:30AM CDT
Zacks Equity Research highlights Rite Aid Corporation (NYSE:RAD-Free Report) as the Bull of the Day and Guess? Inc. (NYSE:GES-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onAmazon (Nasdaq:AMZN-Free Report), Microsoft (Nasdaq:MSFT-Free Report) and Netflix (Nasdaq:NFLX-Free Report).

Bull of the Day: Rite Aid (RAD) - Bull of the Day
Neena Mishra - ZACKS - Fri Apr 25, 3:50AM CDT
Bull of the Day: Rite Aid (RAD) - Bull of the Day

Is Rite Aid Gaining on CVS and Walgreen?
Kyle Colona, The Motley Fool - Motley Fool - Thu Apr 24, 11:21AM CDT
Rite Aid has been under the weather these past few years, but its last earnings report shows the retail chain is on the road to recovery. In fact, Rite Aid's recent initiatives starting with remodeling stores and the acquisition of Texas-based...

Insider Trading Research for Micron, Facebook, Rite Aid, Zynga, Plug Power, and Apple
PR Newswire - Thu Apr 24, 7:55AM CDT
Today, US stock investors can access these reports through the links below, including stock performance, insider trading signals, and visual results. Insiderslab.com released the latest insider trading research for Micron (NASDAQ:MU), Facebook (NASDAQ:FB), Rite Aid (NYSE:RAD), Zynga (NASDAQ:ZNGA), Plug Power (NASDAQ LUG), and Apple (NASDAQ:AAPL).

Most active New York Stock Exchange-traded stocks
AP - Wed Apr 23, 12:37PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:

New Product Collections, Stock Price Movements, Company Updates, and Acquisitions - Analyst Notes on Target, Sysco, Vipshop, Pandora and Rite Aid
PR Newswire - Wed Apr 23, 8:33AM CDT
Today, Analysts Review released its analysts' notes regarding Target Corp. (NYSE: TGT), Sysco Corp (NYSE: SYS), Vipshop Holdings Limited (NYSE: VIPS), Pandora Media, Inc. (NYSE: P) and Rite Aid Corp. (NYSE: RAD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1515-100free.

Walgreen Company: Should Investors Love This Dividend Aristocrat?
Cory Renauer, The Motley Fool - Motley Fool - Tue Apr 22, 5:30PM CDT
We might not have a royal family in the US, but steady income seeking investors are well acquainted with dividend aristocrats like Walgreen . Members of this elite class have steadily increased shareholder distributions during each of the last 25...

Aaron's Lifts Charges Against Vintage Capital - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 3:00PM CDT
Aaron's Inc. lifted litigation charges filed against Vintage Capital Management LLC following the latter's decision to withdraw its takeover bid to acquire the former.

Shares of RAD Up 16.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 22, 11:13AM CDT
SmarTrend identified an Uptrend for Rite Aid (NYSE:RAD) on February 18th, 2014 at $6.16. In approximately 2 months, Rite Aid has returned 16.41% as of today's recent price of $7.17.

Dividends, Drug Trends Report, Upcoming Financial Results, Earnings Results, and Superior Proposal Receipt - Analyst Notes on Walgreens, CVS Caremark, Rite Aid, Cardinal Health, and Chindex
PR Newswire - Tue Apr 22, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Walgreen Co. (NYSE: WAG), CVS Caremark Corporation (NYSE: CVS), Rite Aid Corp. (NYSE: RAD), Cardinal Health, Inc. (NYSE: CAH), and Chindex International Inc. (NASDAQ: CHDX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Your Next Stock Should Be Making New Highs - Screen of the Week
Kevin Matras - ZACKS - Tue Apr 22, 2:30AM CDT
Your Next Stock Should Be Making New Highs - Screen of the Week

Vintage Capital Reacts to Aaron's Rejection - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 2:44PM CDT
Vintage Capital Management LLC came up with the much awaited reaction on Friday after facing rejection for the fourth time in acquiring Aaron's.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 286

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 238

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 131

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 0

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 0

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading